Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100267052 | 10026705 | 2 | F | 201402 | 20141224 | 20140321 | 20141231 | EXP | JP-AMGEN-JPNSP2014019339 | AMGEN | 88.00 | YR | E | M | Y | 55.50000 | KG | 20141231 | N | PH | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100267052 | 10026705 | 1 | PS | VECTIBIX | PANITUMUMAB | 1 | INTRAVENOUS DRIP | 340 MG, Q2WK | 1020 | MG | D | 125147 | 340 | MG | SOLUTION FOR INJECTION | QOW | |||
| 100267052 | 10026705 | 2 | SS | VECTIBIX | PANITUMUMAB | 1 | 1020 | MG | D | 125147 | SOLUTION FOR INJECTION | ||||||||
| 100267052 | 10026705 | 3 | C | ECARD | CANDESARTAN CILEXETILHYDROCHLOROTHIAZIDE | 1 | ORAL | 1 UNK, QD | D | 0 | TABLET | QD | |||||||
| 100267052 | 10026705 | 4 | C | BARACLUDE | ENTECAVIR | 1 | ORAL | 0.5 MG, QD | U | 0 | .5 | MG | TABLET | QD | |||||
| 100267052 | 10026705 | 5 | C | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | ORAL | 50 MG, QD | U | 0 | 50 | MG | TABLET | QD | |||||
| 100267052 | 10026705 | 6 | C | AMARYL | GLIMEPIRIDE | 1 | ORAL | 0.5 MG, QD | U | 0 | .5 | MG | TABLET | QD | |||||
| 100267052 | 10026705 | 7 | C | BUFFERIN A /00009201/ | 2 | ORAL | 81 MG, QD | U | 0 | 81 | MG | QD | |||||||
| 100267052 | 10026705 | 8 | C | ITOROL | ISOSORBIDE MONONITRATE | 1 | ORAL | 20 MG, BID | U | 0 | 20 | MG | TABLET | BID | |||||
| 100267052 | 10026705 | 9 | C | ALFAROL | ALFACALCIDOL | 1 | ORAL | 0.5 MUG, QD | U | 0 | .5 | UG | CAPSULE | QD | |||||
| 100267052 | 10026705 | 10 | C | LENDORMIN | BROTIZOLAM | 1 | ORAL | 0.25 MG, QD | U | 0 | .25 | MG | TABLET | QD | |||||
| 100267052 | 10026705 | 11 | C | OXALIPLATIN. | OXALIPLATIN | 1 | INTRAVENOUS DRIP | UNK UNK, Q2WEEKS | U | 0 | INJECTION | QOW | |||||||
| 100267052 | 10026705 | 12 | C | OXALIPLATIN. | OXALIPLATIN | 1 | U | 0 | INJECTION | ||||||||||
| 100267052 | 10026705 | 13 | C | FLUOROURACIL. | FLUOROURACIL | 1 | INTRAVENOUS | UNK UNK, Q2WEEKS | U | 0 | INJECTION | QOW | |||||||
| 100267052 | 10026705 | 14 | C | FLUOROURACIL. | FLUOROURACIL | 1 | U | 0 | INJECTION | ||||||||||
| 100267052 | 10026705 | 15 | C | CALCIUM LEVOFOLINATE | LEVOLEUCOVORIN CALCIUM | 1 | INTRAVENOUS DRIP | UNK UNK, Q2WEEKS | U | 0 | INJECTION | QOW | |||||||
| 100267052 | 10026705 | 16 | C | CALCIUM LEVOFOLINATE | LEVOLEUCOVORIN CALCIUM | 1 | U | 0 | INJECTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 100267052 | 10026705 | 1 | Colon cancer |
| 100267052 | 10026705 | 2 | Metastases to liver |
| 100267052 | 10026705 | 3 | Hypertension |
| 100267052 | 10026705 | 4 | Chronic hepatitis B |
| 100267052 | 10026705 | 5 | Type 2 diabetes mellitus |
| 100267052 | 10026705 | 6 | Type 2 diabetes mellitus |
| 100267052 | 10026705 | 7 | Angina pectoris |
| 100267052 | 10026705 | 8 | Angina pectoris |
| 100267052 | 10026705 | 9 | Osteoporosis |
| 100267052 | 10026705 | 10 | Insomnia |
| 100267052 | 10026705 | 11 | Colon cancer |
| 100267052 | 10026705 | 12 | Metastases to liver |
| 100267052 | 10026705 | 13 | Colon cancer |
| 100267052 | 10026705 | 14 | Metastases to liver |
| 100267052 | 10026705 | 15 | Colon cancer |
| 100267052 | 10026705 | 16 | Metastases to liver |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 100267052 | 10026705 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 100267052 | 10026705 | Palmar-plantar erythrodysaesthesia syndrome | |
| 100267052 | 10026705 | Sudden death |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 100267052 | 10026705 | 1 | 20140127 | 20140224 | 0 | |
| 100267052 | 10026705 | 3 | 20140310 | 0 | ||
| 100267052 | 10026705 | 4 | 20140310 | 0 | ||
| 100267052 | 10026705 | 5 | 20140310 | 0 | ||
| 100267052 | 10026705 | 6 | 20140310 | 0 | ||
| 100267052 | 10026705 | 7 | 20140310 | 0 | ||
| 100267052 | 10026705 | 8 | 20140310 | 0 | ||
| 100267052 | 10026705 | 9 | 20140310 | 0 | ||
| 100267052 | 10026705 | 10 | 20140310 | 0 | ||
| 100267052 | 10026705 | 11 | 20140127 | 20140224 | 0 | |
| 100267052 | 10026705 | 13 | 20140127 | 20140224 | 0 | |
| 100267052 | 10026705 | 15 | 20140127 | 20140224 | 0 |